## **Core Concept**
Recurrent Gastrointestinal Stromal Tumors (GISTs) require careful investigation for optimal management. GISTs are mesenchymal tumors of the gastrointestinal tract, often driven by mutations in the **KIT** or **PDGFRA** genes. The investigation of choice for recurrent GIST involves imaging to assess the extent of disease and guide treatment.

## **Why the Correct Answer is Right**
The correct answer, **CT abdomen and pelvis with contrast**, is the investigation of choice for recurrent GIST because it provides detailed images of the abdominal and pelvic structures, allowing for the assessment of tumor size, location, and potential metastasis. **CT scans** are particularly useful for detecting liver and peritoneal metastases, which are common sites for GIST recurrence. The use of **contrast** enhances the visibility of tumors, making it easier to distinguish them from surrounding tissues.

## **Why Each Wrong Option is Incorrect**
- **Option A (X-ray abdomen)**: This is not suitable for detecting soft tissue masses or assessing the extent of disease in GIST recurrence. X-rays are less sensitive for evaluating abdominal and pelvic structures compared to CT scans.
- **Option B (USG abdomen)**: While ultrasound can detect some abdominal abnormalities, it is less sensitive than CT scans for detecting liver and peritoneal metastases. It also provides less detailed information about the tumor's relationship to surrounding structures.
- **Option D (MRI abdomen)**: Although MRI can provide detailed images of soft tissue structures, it is not typically the first choice for investigating recurrent GIST due to its higher cost, lower availability, and longer examination time compared to CT scans. MRI may be used in specific situations, such as evaluating the relationship of the tumor to critical structures.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **CT scans are the preferred imaging modality for monitoring GIST treatment response and detecting recurrence**. This is because CT scans can accurately measure tumor size and assess the tumor's response to targeted therapies, such as tyrosine kinase inhibitors.

## **Correct Answer:** . CT abdomen and pelvis with contrast